Horninger W - Search Results

1

Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.

Pichler R, Borena W, Schäfer G, Manzl C, Culig Z, List S, Neururer S, Von Laer D, Heidegger I, Klocker H, Horninger W, Steiner H, Brunner A. Pichler R, et al. Among authors: horninger w. World J Urol. 2015 Dec;33(12):2145-51. doi: 10.1007/s00345-015-1539-y. Epub 2015 Mar 19. World J Urol. 2015. PMID: 25786709

2

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study.

Reissigl A, Pointner J, Horninger W, Ennemoser O, Strasser H, Klocker H, Bartsch G. Reissigl A, et al. Among authors: horninger w. Urology. 1995 Nov;46(5):662-5. doi: 10.1016/S0090-4295(99)80297-0. Urology. 1995. PMID: 7495117

3

Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening.

Reissigl A, Klocker H, Pointner J, Fink K, Horninger W, Ennemoser O, Strasser H, Colleselli K, Höltl L, Bartsch G. Reissigl A, et al. Among authors: horninger w. Urology. 1996 Dec;48(6A Suppl):62-6. doi: 10.1016/s0090-4295(96)00612-7. Urology. 1996. PMID: 8973702

4

PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors.

Reissigl A, Pointner J, Horninger W, Strasser H, Mayersbach P, Klocker H, Schönitzer D, Bartsch G. Reissigl A, et al. Among authors: horninger w. Prostate. 1997 Jan 1;30(1):20-5. doi: 10.1002/(sici)1097-0045(19970101)30:1<20::aid-pros3>3.0.co;2-p. Prostate. 1997. PMID: 9018331

5

Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.

Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G. Reissigl A, et al. Among authors: horninger w. Cancer. 1997 Nov 1;80(9):1818-29. doi: 10.1002/(sici)1097-0142(19971101)80:9<1818::aid-cncr21>3.0.co;2-7. Cancer. 1997. PMID: 9351555

6

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. Hobisch A, et al. Among authors: horninger w. Cancer Res. 1998 Oct 15;58(20):4640-5. Cancer Res. 1998. PMID: 9788616

7

Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels.

Horninger W, Reissigl A, Klocker H, Rogatsch H, Fink K, Strasser H, Bartsch G. Horninger W, et al. Prostate. 1998 Nov 1;37(3):133-7; discussion 138-9. doi: 10.1002/(sici)1097-0045(19981101)37:3<133::aid-pros1>3.0.co;2-w. Prostate. 1998. PMID: 9792130

8

Prostate cancer screening in Tyrol, Austria: experience and results.

Horninger W, Reissigl A, Rogatsch H, Volgger H, Studen M, Klocker H, Bartsch G. Horninger W, et al. Eur Urol. 1999;35(5-6):523-38. doi: 10.1159/000019893. Eur Urol. 1999. PMID: 10325519

9

Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening.

Horninger W, Rogatsch H, Reissigl A, Volgger H, Klocker H, Hobisch A, Bartsch G. Horninger W, et al. Prostate. 1999 Jun 15;40(1):56-61. doi: 10.1002/(sici)1097-0045(19990615)40:1<56::aid-pros7>3.0.co;2-e. Prostate. 1999. PMID: 10344724

10

Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate.

Ischia R, Hobisch A, Bauer R, Weiss U, Gasser RW, Horninger W, Bartsch G Jr, Fuchs D, Bartsch G, Winkler H, Klocker H, Fischer-Colbrie R, Culig Z. Ischia R, et al. Among authors: horninger w. J Urol. 2000 Apr;163(4):1161-4; discussion 1164-5. J Urol. 2000. PMID: 10737487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters